Contributor Page
Generics Web
 
Email  |  Articles
Contact Details
Fax: +61 02 9262 7636
Level 7
503 - 505 Kent Street
Sydney
Australia
By Mahesh Yeganathan
Valsartan, an angiotensin II receptor antagonist, developed by Novartis and marketed as its flagship-product, is sold under the brand name Diovan.
By John Zhicong He
Docetaxel, a taxane type anticancer drug, developed by Sanofi-Aventis and marketed under the brand name of Taxotere, lost its molecule patent protections in US and major European jurisdictions last month.
By Kevin Wang
Donepezil (Aricept®), an anti-dementia/anti-Alzheimer's treatment developed by Eisai and co-marketed by Pfizer, will lose key patent protection in some major territories in the near future. Currently, Aricept® is the world's best selling anti-Alzheimer's drug and generated sales of 303 billion Japanese Yen for Eisai and US$432 million for Pfizer in 2009. Based on the information contained in GenericsWeb's Donepezil Pipeline Selector report, this month's Drug In Focus will analyse the patent land
By Colleen Bray
The Anastrozole General Information indicates that Arimidex is available as 1 mg film coated tablets and generally carries three indications relating to the treatment of breast cancer.